| Effects of a Weight Loss Program on Metabolic Syndrome, Eating Disorders and Psychological Outcomes: Mediation by Endocannabinoids? | Obesity Facts |  | | 2018 | 491 | 0 |
|
| Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways | Thrombosis and haemostasis | | | 2015 | 798 | 0 |
|
| Déficiences micronutritionnelles chez les patients obèses | Revue médicale suisse | | | 2013 | 555 | 0 |
|
| Fasting insulin at baseline influences the number of cardiometabolic risk factors and R-R interval at 3years in a healthy population: The RISC Study | Diabetes & metabolism | | | 2013 | 616 | 1 |
|
| Coronary Vasomotor Control in Obesity and Morbid Obesity | JACC. Cardiovascular imaging |  | | 2012 | 767 | 706 |
|
| Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity | European heart journal | | | 2011 | 676 | 0 |
|
| Relationship between sympathetic reactivity and body weight loss in morbidly obese subjects | International journal of obesity | | | 2004 | 799 | 0 |
|
